Literature DB >> 24080916

Detecting mood disorder in resource-limited primary care settings: comparison of a self-administered screening tool to general practitioner assessment.

Paul A Vöhringer1, Mirtha I Jimenez, Mirko A Igor, Gonzalo A Fores, Matias O Correa, Matthew C Sullivan, Niki S Holtzman, Elizabeth A Whitham, Sergio A Barroilhet, Katherine Alvear, Tanya Logvinenko, David M Kent, Nassir S Ghaemi.   

Abstract

OBJECTIVES: Although efficacious treatments for mood disorders are available in primary care, under-diagnosis is associated with under-treatment and poorer outcomes. This study compares the accuracy of self-administered screening tests with routine general practitioner (GP) assessment for detection of current mood disorder.
METHODS: 197 consecutive patients attending primary care centres in Santiago, Chile enrolled in this cross-sectional study, filling out the Patients Health Questionnaire-9 (PHQ-9) for depression and the Mood Disorder Questionnaire (MDQ) for bipolar disorder, after routine GP assessment. Diagnostic accuracy of these self-administered tools was compared with GP assessment, with gold standard diagnosis established by a structured diagnostic interview with trained clinicians (SCID-I).
RESULTS: The sample was 75% female, with a mean age of 48.5 (SD 16.8); 37% had a current mood disorder (positive SCID-I result for depression or bipolar disorder). Sensitivity of the screening instruments (SI) was substantially higher than GP assessment (SI: 0.8, [95% CI 0.71, 0.81], versus GP: 0.2, [95% CI 0.12, 0.25]: p-value < 0.0001), without sacrifice in specificity (SI: 0.9, [95% CI 0.86, 0.96], versus GP: 0.9, [95% CI 0.88, 0.97]: p-value = 0.7). This led to improvement in both positive predictive value (SI: 0.8, [95% CI 0.82, 0.90], versus GP: 0.6, [95% CI 0.50, 0.64]: p-value < 0.001) and negative predictive value (SI: 0.9, [95% CI 0.78, 0.91] versus GP: 0.7, [95% CI 0.56, 0.72]: p-value < 0.01).
CONCLUSION: Self-administered screening tools are more accurate than GP assessment in detecting current mood disorder in low-income primary care. Such screening tests may improve detection of current mood disorder if implemented in primary care settings.

Entities:  

Keywords:  Bipolar Disorder; Depression; Mental health; Mood Disorders; Primary care; Screening

Mesh:

Year:  2013        PMID: 24080916     DOI: 10.1177/0969141313503954

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Medical and Welfare Officers beliefs about post-deployment screening for mental health disorders in the UK Armed Forces: a qualitative study.

Authors:  Samantha Bull; Gursimran Thandi; Mary Keeling; Melanie Chesnokov; Neil Greenberg; Norman Jones; Roberto Rona; Stephani L Hatch
Journal:  BMC Public Health       Date:  2015-04-09       Impact factor: 3.295

2.  Computer-Assisted Cognitive-Behavioral Therapy to Treat Adolescents With Depression in Primary Health Care Centers in Santiago, Chile: A Randomized Controlled Trial.

Authors:  Vania Martínez; Graciela Rojas; Pablo Martínez; Jorge Gaete; Pedro Zitko; Paul A Vöhringer; Ricardo Araya
Journal:  Front Psychiatry       Date:  2019-07-30       Impact factor: 4.157

3.  Selective cutoff reporting in studies of the accuracy of the Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale: Comparison of results based on published cutoffs versus all cutoffs using individual participant data meta-analysis.

Authors:  Dipika Neupane; Brooke Levis; Parash M Bhandari; Brett D Thombs; Andrea Benedetti
Journal:  Int J Methods Psychiatr Res       Date:  2021-05-12       Impact factor: 4.182

4.  Remote Collaborative Depression Care Program for Adolescents in Araucanía Region, Chile: Randomized Controlled Trial.

Authors:  Vania Martínez; Graciela Rojas; Pablo Martínez; Pedro Zitko; Matías Irarrázaval; Carolina Luttges; Ricardo Araya
Journal:  J Med Internet Res       Date:  2018-01-31       Impact factor: 5.428

5.  A Remote Collaborative Care Program for Patients with Depression Living in Rural Areas: Open-Label Trial.

Authors:  Graciela Rojas; Viviana Guajardo; Pablo Martínez; Ariel Castro; Rosemarie Fritsch; Markus Moessner; Stephanie Bauer
Journal:  J Med Internet Res       Date:  2018-04-30       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.